Pages that link to "Q28240424"
Jump to navigation
Jump to search
The following pages link to Selecting effective antisense reagents on combinatorial oligonucleotide arrays (Q28240424):
Displaying 50 items.
- Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes (Q24527367) (← links)
- Predicting oligonucleotide affinity to nucleic acid targets (Q24539440) (← links)
- Sfold web server for statistical folding and rational design of nucleic acids (Q24562042) (← links)
- Profiled support vector machines for antisense oligonucleotide efficacy prediction (Q24792682) (← links)
- Morpholino antisense oligonucleotides: tools for investigating vertebrate development (Q24805526) (← links)
- Molecular interactions on microarrays (Q28294836) (← links)
- Silencing disease genes in the laboratory and the clinic (Q29039090) (← links)
- Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase. (Q30662658) (← links)
- Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA. (Q30704352) (← links)
- A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells (Q30840951) (← links)
- HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture (Q30953558) (← links)
- mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides (Q30961001) (← links)
- MicroRNAs align with accessible sites in target mRNAs (Q30975689) (← links)
- Structural rearrangements in RNA on the binding of an antisense oligonucleotide: implications for the study of intra-molecular RNA interactions and the design of cooperatively acting antisense reagents with enhanced efficacy (Q31162615) (← links)
- Technology for microarray analysis of gene expression (Q31934094) (← links)
- Modulation of RNA function by oligonucleotides recognizing RNA structure (Q31971747) (← links)
- A genomic selection strategy to identify accessible and dimerization blocking targets in the 5'-UTR of HIV-1 RNA (Q33202244) (← links)
- Selection of antisense oligonucleotides based on multiple predicted target mRNA structures (Q33235952) (← links)
- A structural analysis of in vitro catalytic activities of hammerhead ribozymes (Q33308295) (← links)
- Feasibility of transferring fluorescent in situ hybridization probes to an 18S rRNA gene phylochip and mapping of signal intensities (Q33322992) (← links)
- Improvement of RNA secondary structure prediction using RNase H cleavage and randomized oligonucleotides (Q33481558) (← links)
- Powerful tools for genetic analysis come of age. (Q33586069) (← links)
- Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides (Q33607807) (← links)
- Antisense--time to shoot the messenger (Q33693109) (← links)
- Pharmacology of antisense oligonucleotide inhibitors of protein expression (Q33716194) (← links)
- Functional analysis of newly discovered growth control genes: experimental approaches (Q33716358) (← links)
- Mutational analysis using oligonucleotide microarrays (Q33755554) (← links)
- Sensible use of antisense: how to use oligonucleotides as research tools (Q33818938) (← links)
- Morpholino antisense oligomers: the case for an RNase H-independent structural type (Q33901587) (← links)
- Oligonucleotide therapeutics for hematologic disorders (Q33916119) (← links)
- Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease (Q33970374) (← links)
- The delivery of antisense therapeutics (Q34062621) (← links)
- Selecting optimal antisense reagents (Q34062626) (← links)
- Rational selection of antisense oligonucleotide sequences (Q34066379) (← links)
- Controlling the mitochondrial gatekeeper for effective chemotherapy (Q34089134) (← links)
- Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA (Q34179717) (← links)
- The cellular delivery of antisense oligonucleotides and ribozymes (Q34189367) (← links)
- Mapping targetable sites on human telomerase RNA pseudoknot/template domain using 2'-OMe RNA-interacting polynucleotide (RIPtide) microarrays (Q34208911) (← links)
- A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNase H. (Q34268755) (← links)
- Antisense oligonucleotides in cutaneous therapy (Q34305862) (← links)
- Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides (Q34351307) (← links)
- Prioritized selection of oligodeoxyribonucleotide probes for efficient hybridization to RNA transcripts (Q34486348) (← links)
- Antisense as a neuroscience tool and therapeutic agent (Q34553851) (← links)
- Isoenergetic penta- and hexanucleotide microarray probing and chemical mapping provide a secondary structure model for an RNA element orchestrating R2 retrotransposon protein function (Q34588002) (← links)
- A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures (Q34646063) (← links)
- The effect of structure in a long target RNA on ribozyme cleavage efficiency (Q34646173) (← links)
- Nucleic-acid therapeutics: basic principles and recent applications (Q34743204) (← links)
- Screening for antisense modulation of dystrophin pre-mRNA splicing (Q34807136) (← links)
- Microarrays for identifying binding sites and probing structure of RNAs (Q34883490) (← links)
- Antisense therapy for cancer--the time of truth (Q34992794) (← links)